EPCAM and neoplasm: This method involves immune-affinity separation using antibodies against the Epithelial Cell Adhesion Molecule (EpCAM), leading to the selective isolation of a particular CTC phenotype that is likely not completely representative of all the cells being shed from the tumor and can potentially impact outcomes of gene expression analyses [22–25].